Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults

NCT00259831 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Upper Respiratory Infection

Interventions

DRUG: CVT-E002 (Cold-FX); a natural health product

Sponsor

CV Technologies

Collaborators

[object Object]